Recent studies have demonstrated that arsenic trioxide (As2O3) exerts antitumor effects not only on acute promyelocytic leukemia (APL) but also on a variety of solid tumors that include liver cancer. In this paper, the authors, after retrieval and extraction of domestic and foreign literature, address the research progress on the mechanism of arsenic trioxide action on liver cancer and its clinical application.